CMS releases results from the first round of Medicare Drug Price Negotiations, Steward finds a buyer for its physician group, and employers are using price transparency data in their suits against Aetna.

Community Health Systems plans to sell its three Pennsylvania hospitals, a bankruptcy judge allows Steward Health Care to close two Massachusetts hospitals, and CMS approves North Carolina’s medical debt relief program.

This Sg2 Perspectives podcast, featuring Kaufman Hall Senior VP Adnan Qureshi, offers insights on current trends in private equity deals and perspectives on how private equity can help healthcare.

As healthcare market conditions continue to stabilize after several years of pandemic-era volatility, many hospital and health system leaders are revisiting their organizations’ strategic options for long-term sustainability.

The latest Kaufman Hall Report includes an inside look at resetting organizational enterprise strategy.

A judge orders a partial, preliminary injunction of the FTC’s noncompete ban, Sanford Health and Marshfield Clinic announce plans to combine, and CMS proposes a nearly 3% cut to Medicare physician pay for 2025.

Watch an engaging discussion with Moody’s, Fitch and S&P on their latest industry outlooks and hear top-of-mind topics including cyber preparedness, financial performance and capital spending as we head into the second half of the year, and contemporary strategies for long-term sustainability.

Evolving industry dynamics will prompt further consolidation among not-for-profit life plan communities, especially as organizations look to add scale to their platforms. This activity will have strategic implications for LPC organizations of all sizes.

M&A activity in Q2 2024 slowed from a very busy Q1, with 11 announced transactions. Several large transactions in the quarter, however, generated an average seller size by revenue that significantly exceeded year-end averages dating back to 2017.

Health systems are faced with two conflicting realities. The first is that partnerships will continue to be a necessary and critical part of healthcare strategy. The second is that antitrust enforcement will continue to create strong barriers to these same partnerships.